TA-101

N/A

Report date: 2025/01/26 16:24:59

Base Information

Drug NameTA-101

Drug Alias Namerecombinant single domain antibody fragment (Technophage)TA-101

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionTumor necrosis factor α inhibitors

TargetsTumor necrosis factor α

Therapy Area/IndicationsInflammationEye DiseasesArthritis, Rheumatoid

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryPortugal

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTechnophage SA

China Registration ClassN/A

Develop Information

Active CompaniesTechnophage SA

Inactive CompaniesN/A

Active IndicationsArthritis, Rheumatoid

Inactive IndicationsInflammationEye Diseases

Other Information

ATC CodeN/A